ACQUIRED HEMOPHILIA A FOLLOWING AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HIGH-RISK NEUROBLASTOMA

被引：0
|
作者：
Mitani, Yuichi [1 ]
Arakawa, Yuki [1 ]
Mori, Makiko [1 ]
Fukuoka, Kohei [1 ]
Oshima, Koichi [1 ]
Niitsu, Takehiro [2 ]
Kawashima, Hiroshi [3 ]
Fujinaga, Shuichiro [4 ]
Koh, Katsuyoshi [1 ]
机构：
[1] Saitama Childrens Med Ctr, Dept Hematol Oncol, Saitama, Japan
[2] Saitama Childrens Med Ctr, Dept Crit Care Med, Saitama, Japan
[3] Saitama Childrens Med Ctr, Dept Pediat Surg, Saitama, Japan
[4] Saitama Childrens Med Ctr, Div Nephrol, Saitama, Japan
来源：
PEDIATRIC BLOOD & CANCER | 2022年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OS11-3
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [31] The efficacy of tandem stem cell transplantation in patients with high-risk neuroblastoma
    Sugiyama, M.
    Terashita, Y.
    Ohshima, J.
    Cho, Y.
    Iguchi, A.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S309 - S310
  • [32] Survival Benefit of Myeloablative Therapy with Autologous Stem Cell Transplantation in High-Risk Neuroblastoma: A Systematic Literature Review
    Urszula Żebrowska
    Walentyna Balwierz
    Jarosław Wechowski
    Aleksandra Wieczorek
    Targeted Oncology, 2024, 19 : 143 - 159
  • [33] Survival Benefit of Myeloablative Therapy with Autologous Stem Cell Transplantation in High-Risk Neuroblastoma: A Systematic Literature Review
    Zebrowska, Urszula
    Balwierz, Walentyna
    Wechowski, Jaroslaw
    Wieczorek, Aleksandra
    TARGETED ONCOLOGY, 2024, 19 (02) : 143 - 159
  • [34] Retinoic acid postconsolidation therapy for high-risk neuroblastoma patients treated with autologous haematopoietic stem cell transplantation
    Peinemann, Frank
    van Dalen, Elvira C.
    Enk, Heike
    Berthold, Frank
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (08):
  • [35] EARLY INFECTIOUS COMPLICATIONS FOLLOWING AUTOLOGOUS STEM CELL TRANSPLANT FOR HIGH-RISK NEUROBLASTOMA: HIGH IMPACT ON MORTALITY AND MORBIDITY
    Noun, Dolly
    Ghanem, Khaled
    Dhayni, Raghida
    Hariss, Nariman
    Muakkit, Samar
    Saab, Raya
    Hamideh, Dima
    El-Solh, Hassan
    Abboud, Miguel
    Tarek, Nidale
    PEDIATRIC BLOOD & CANCER, 2018, 65
  • [36] Outcome of children with relapsed high-risk neuroblastoma in Japan and analysis of the role of allogeneic hematopoietic stem cell transplantation
    Hara, Junichi
    Nitani, Chika
    Shichino, Hiroyuki
    Kuroda, Tatsuo
    Hishiki, Tomoro
    Soejima, Toshinori
    Mori, Tetsuya
    Matsumoto, Kimikazu
    Sasahara, Yoji
    Iehara, Tomoko
    Miyamura, Takako
    Kosaka, Yoshiyuki
    Takimoto, Tetsuya
    Nakagawara, Akira
    Tajiri, Tatsuro
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2022, 52 (05) : 486 - 492
  • [37] AUTOLOGOUS BLOOD STEM-CELL TRANSPLANTATION IN HIGH-RISK MYELOMA
    MARIT, G
    BOIRON, JM
    REIFFERS, J
    BONE MARROW TRANSPLANTATION, 1990, 5 : 55 - 55
  • [38] Autologous stem cell transplantation for high-risk pediatric solid tumors
    JP Perentesis
    E Katsanis
    TE DeFor
    JP Neglia
    NKC Ramsay
    Bone Marrow Transplantation, 1999, 24 : 609 - 615
  • [39] Autologous stem cell transplantation for high-risk pediatric solid tumors
    Perentesis, JP
    Katsanis, E
    DeFor, TE
    Neglia, JP
    Ramsay, NKC
    BONE MARROW TRANSPLANTATION, 1999, 24 (06) : 609 - 615
  • [40] IMMUNE PHENOTYPE IS HIGHLY VARIABLE LEADING UP TO DINUTUXIMAB THERAPY FOLLOWING AUTOLOGOUS STEM CELL TRANSPLANTATION AND AT RELAPSE IN PATIENTS WITH HIGH-RISK NEUROBLASTOMA
    Suntum, Tara
    Siddiqui, Amir
    Cheong, Rudolph
    Nassin, Michele
    Cohn, Susan
    LaBelle, James
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S222 - S223
12345